Your browser doesn't support javascript.
Leveraging the advances in HIV for COVID-19.
McMahon, James H; Hoy, Jennifer F; Kamarulzaman, Adeeba; Bekker, Linda-Gail; Beyrer, Chris; Lewin, Sharon R.
  • McMahon JH; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia; Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC, Australia.
  • Hoy JF; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Kamarulzaman A; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Beyrer C; Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Lewin SR; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC, Australia; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hos
Lancet ; 396(10256): 943-944, 2020 10 03.
Article in English | MEDLINE | ID: covidwho-997643
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / HIV Infections / Coronavirus Infections / Pandemics Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)32012-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / HIV Infections / Coronavirus Infections / Pandemics Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Year: 2020 Document Type: Article Affiliation country: S0140-6736(20)32012-2